Correlation Between X4 Pharmaceuticals and BriaCell Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on X4 Pharmaceuticals and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and BriaCell Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and BriaCell Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between XFOR and BriaCell is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and BriaCell Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and BriaCell Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 0.99 times more return on investment than BriaCell Therapeutics. However, X4 Pharmaceuticals is 1.02 times less risky than BriaCell Therapeutics. It trades about 0.05 of its potential returns per unit of risk. BriaCell Therapeutics Corp is currently generating about 0.03 per unit of risk. If you would invest 66.00 in X4 Pharmaceuticals on September 26, 2024 and sell it today you would lose (8.00) from holding X4 Pharmaceuticals or give up 12.12% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.41% |
Values | Daily Returns |
X4 Pharmaceuticals vs. BriaCell Therapeutics Corp
Performance |
Timeline |
X4 Pharmaceuticals |
BriaCell Therapeutics |
X4 Pharmaceuticals and BriaCell Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with X4 Pharmaceuticals and BriaCell Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.X4 Pharmaceuticals vs. Fate Therapeutics | X4 Pharmaceuticals vs. Caribou Biosciences | X4 Pharmaceuticals vs. Karyopharm Therapeutics | X4 Pharmaceuticals vs. Hookipa Pharma |
BriaCell Therapeutics vs. Fate Therapeutics | BriaCell Therapeutics vs. Caribou Biosciences | BriaCell Therapeutics vs. Karyopharm Therapeutics | BriaCell Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |